Lenz Therapeutics, Inc.

LENZ·NASDAQ·$7.75Share Price as of 11/2·$243MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/24/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2507/30/25

Disclosures

8-KCurrent report10/28/26 8-KCurrent report08/11/26 8-KCurrent report07/02/26 8-KCurrent report06/12/26 8-KCurrent report05/11/26

Prospectuses and Registrations

S-8Registration of securities for employees03/24/26 424B3Prospectus04/14/25 424B5Prospectus supplement04/14/25 424B3Prospectus04/09/25 424B3Prospectus04/09/25

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25 DEF 14ADefinitive proxy06/06/23

Ownership

SC 13GBeneficial ownership10/27/26 SC 13G/ABeneficial ownership (amended)10/21/26 SC 13G/ABeneficial ownership (amended)09/08/26 SC 13GBeneficial ownership06/26/26 Form 4Insider transaction06/15/26

Other

ARSAnnual report to shareholders04/28/26 ARSAnnual report to shareholders04/28/25 EFFECTRequest for effectiveness04/14/25 EFFECTRequest for effectiveness04/14/25 CORRESPCorrespondence with the SEC04/10/25